Imagine discovering that a common childhood lung infection could silently sneak up and harm a young heart—something that might sound like a plot from a medical thriller, but it's a real concern for parents and doctors alike. This eye-opening research dives into how Mycoplasma pneumoniae pneumonia (MPP) in kids ties into heart damage, spotlighting key players like vitamin D levels, a heart stress marker called NT-proBNP, and a crew of inflammatory substances. But here's where it gets intriguing: could low vitamin D really be the culprit behind these cardiac complications, or is there more to the story that challenges our assumptions? Let's unpack this study together, step by step, to see why it matters for every child battling MPP.
Exploring Links: Vitamin D, NT-proBNP, Inflammation, and Heart Harm in Kids with MPP
Research Paper
Freely Accessible (via Springer Nature's Open Science Initiative)
Released: November 7, 2025
Yingjie Liu¹ & Ping Li¹
BMC Pediatrics (from BioMed Central) volume 25, Article 914 (2025) Cite this piece
Abstract
Purpose
Our investigation aimed to uncover the connections between heart muscle damage in young patients with Mycoplasma pneumoniae pneumonia (MPP) and shifts in blood levels of 25-hydroxyvitamin D (often just called 25-(OH)-D), N-terminal pro-brain natriuretic peptide (NT-proBNP), and various inflammation-related markers. These markers include tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and high-sensitivity C-reactive protein (hs-CRP).
Methods
We analyzed data from 300 hospitalized children diagnosed with MPP at Zhangye People’s Hospital, linked to Hexi College, from January to December 2023. Kids showing signs of heart injury were placed in Group A, while those without formed Group B. We tested and contrasted the two groups' blood concentrations of NT-proBNP, 25-(OH)-D, and the inflammation markers mentioned.
Findings
Statistical tests like Pearson correlation analysis revealed clear ties between heart damage and changes in 25-(OH)-D, NT-proBNP, and the inflammatory markers in MPP-affected children. Group A had notably lower 25-(OH)-D levels compared to Group B (with a p-value under 0.05), but higher amounts of NT-proBNP, TNF-α, IL-1β, IL-6, and hs-CRP (again, p < 0.05). The correlation analysis pointed to potential links between heart injury onset in MPP cases and the levels of these very same substances.
Key Takeaways
The evidence suggests that MPP patients might face heart injury when 25-(OH)-D drops and NT-proBNP plus inflammatory factors rise. Clinicians should watch these markers closely during treatment to catch issues early.
Peer Reviewer Insights (accessible here)
Background
Mycoplasma pneumoniae pneumonia (MPP) stands out as a contagious lung inflammation sparked by Mycoplasma pneumoniae infection, spreading easily through droplets or close contact [1]. It's particularly tricky for children due to weaker immune systems, making them more prone. Statistically, MPP makes up 10% to 33% of all pneumonia cases, hitting 10% to 60% of pediatric patients [2]. Symptoms like tiredness, fever, and cough typically show up 1 to 3 weeks after infection [3]. As the illness intensifies, the infection's inflammatory response can extend to the heart, triggering myocarditis that leads to arrhythmias, circulation problems, and even heart failure—posing life-threatening risks [4]. Understanding the triggers of heart damage and spotting early signals is vital for preventing and managing this in kids.
Immune adjustments, physical stress, and inflammatory triggers all factor into MPP's progression [5]. Among these, 25-hydroxyvitamin D (25-(OH)-D), the main circulating form of vitamin D, plays a big role in immune regulation and fighting infections [6]. Low 25-(OH)-D in MPP kids weakens immunity, raising infection risks [7]. Meanwhile, NT-proBNP acts as a key indicator of heart strain, used to gauge heart health and heart failure severity [8]. Clinical observations suggest MPP-related heart injury might elevate NT-proBNP due to damaged heart cells reducing function [9].
Inflammation markers like TNF-α, IL-1β, IL-6, and hs-CRP are central to the inflammatory process [10]. Their levels rise in MPP children as a natural defense against pathogens, mirroring inflammation intensity [11]. For instance, higher TNF-α indicates a strong immune reaction, potentially linked to disease severity and outcomes [12]. Elevated IL-1β might fuel systemic inflammatory response syndrome (SIRS) [13], while IL-6, a versatile cytokine, rises with infection strength and duration [14]. Plus, hs-CRP, an acute-phase protein, spikes quickly during inflammation [15].
Yet, research gaps persist on how exactly blood 25-(OH)-D, NT-proBNP, and inflammation markers cause heart injury in MPP kids. To address this, our team merged pathological insights with a review of 300 MPP cases from January to December 2023. We delved into correlations between blood 25-(OH)-D, NT-proBNP, inflammation markers, and heart damage in these children. By exploring these links, we aim to spark fresh ideas for diagnosis and care, offering clues to better understand how MPP impacts young hearts.
Methods
Participant Details
We drew from 300 MPP-diagnosed kids admitted to Zhangye People’s Hospital, affiliated with Hexi College, between January and December 2023. All met the 2020 SATS guidelines for community-acquired pneumonia in children, confirmed via symptoms, imaging, lab tests, and PCR for Mycoplasma pneumoniae DNA. After initial screening, we excluded two due to sample issues, leaving 298 for analysis. Group A (GA) included 106 with heart injury, confirmed by ECG, blood tests, and heart ultrasounds. Group B (GB) had 192 without injury.
Inclusion Rules
(a) Kids in both groups fit the 2020 SATS pneumonia guidelines [16]. (b) GA members showed heart injury via ECG changes (like ST shifts or T-wave inversions, QT over 440 ms), cardiac troponin >0.2 µg/L, and creatine kinase-MB >25.0 U/L. (c) Ages ranged from 1 to 6 years. (d) Records were complete. (e) Families cooperated actively.
Exclusion Rules
(a) Other respiratory issues. (b) Immune disorders. (c) Mental health conditions. (d) Heart defects.
Removal Rules
(a) Bad samples. (b) Data errors.
Heart Injury Criteria
(a) Two cardiologists independently reviewed blindly: ST depression/elevation >0.1 mV, T-wave inversions in two+ leads, or QTc >440 ms. (b) Left ventricular ejection fraction <55%, or motion issues. (c) Cardiac troponin I >0.2 µg/L (using ARCHITECT i2000SR), creatine kinase-MB >25.0 U/L (rate method).
Testing Approach
We used a form for collecting kids' blood markers, including 25-(OH)-D, NT-proBNP, TNF-α, IL-1β, IL-6, and hs-CRP. Blood (5 mL) came from routine draws, spun at 3200 rpm for 10 minutes at 10 cm radius, then stored at -20°C. 25-(OH)-D tested via ELISA (kit E-EL-H0109c, Elabscience) with 0.5 nmol/L sensitivity, 5% intra-assay CV, 8% inter-assay. NT-proBNP via EIA (Roche 1177767322) at 5 ng/L sensitivity, 4% intra-CV, 6% inter-CV. Inflammation markers on Siemens ADVIA Centaur XP: hs-CRP at 0.1 mg/L sensitivity, cytokines <1 pg/mL, CVs <7% both ways.
Thresholds: NT-proBNP >300 ng/L for pediatric heart failure (per 2020 AHA). ROC set 25-(OH)-D ≤58 nmol/L (AUC 0.76) and hs-CRP ≥5.5 mg/L (AUC 0.82) from 50 early samples.
Data Collection Process
Our self-made form helped gather markers. The team—two pediatricians (5+ years experience) and three trained nurses—handled measurements, form-filling, and testing. Forms were checked on-site, signed, and collected (100% response rate for 298). We validated ELISA, EIA, and immunoassay use.
Analysis Tools
SPSS 26.0 processed data. Kolmogorov-Smirnov checked normality; normally distributed data as mean ± SD (x̄ ± s), with t-tests. Counts as n (%), χ² tests. Pearson correlation analyzed ties between markers and heart injury, adjusting for age, gender, BMI. p < 0.05 meant significance.
Results
Baseline Group Comparisons
From 300 kids, two samples were invalid. Remaining: GA n=106, GB n=192. Table 1 (link) showed no significant group differences in basics (p > 0.05).
25-(OH)-D and NT-proBNP Group Comparisons
Table 2 (link): GA had lower 25-(OH)-D, higher NT-proBNP than GB (p < 0.05). Fig. 1 (link) echoed this, with medians showing GA lower in 25-(OH)-D, higher in NT-proBNP. (Note: Charts depict levels with markers for medians; **** for p < 0.001.)
Inflammation Marker Group Comparisons
Table 3 (link): GA elevated in TNF-α, IL-1β, IL-6, hs-CRP vs. GB (p < 0.05). Fig. 2 (link) confirmed higher medians. (Similar note on charts.)
Correlation Study on 25-(OH)-D, NT-proBNP, Inflammation Markers, and Heart Injury in MPP Kids
Pearson correlations linked heart injury to 25-(OH)-D (r = 0.305, p < 0.05), and negatively to NT-proBNP, TNF-α, IL-1β, IL-6, hs-CRP (r = -0.365 to -0.537, p < 0.05). Fig. 3 (link) heatmap visualized this (red positive, blue negative). Scatter plots in Fig. 4 (link) showed good linear fits with regression lines.
Advanced Analysis Findings
Logistic regression, adjusting for age, BMI, illness duration, flagged low 25-(OH)-D (OR=0.82, 95% CI 0.75-0.90), high NT-proBNP (OR=1.03, 1.01-1.05), high IL-6 (OR=1.48, 1.22-1.79) as independent heart injury risks (p < 0.001). See Table 4 (link).
Discussion
Rising MPP cases in kids up heart injury risks, urging better diagnosis and treatment paths. This study probes ties between blood 25-(OH)-D, NT-proBNP, inflammation markers, and MPP heart damage. 25-(OH)-D, vitamin D's main form, supports bones and mineral balance [17], but also ties to non-bone issues like heart disease [18-19]. Low 25-(OH)-D links to poorer immunity, heightening MPP susceptibility [22]. NT-proBNP rises with heart stress or damage [20], signaling heart failure [26-27]. Inflammation aids MPP but can harm hearts via cytokines [21].
Our findings connect low 25-(OH)-D to higher heart injury risks in MPP kids—when it drops, inflammation amps up, affecting heart cells [22-24]. NT-proBNP spikes as ventricles secrete more to ease load [25,28-29]. Inflammation markers like TNF-α, IL-1β, IL-6, hs-CRP drive damage [30-40]. But here's where it gets controversial: is vitamin D supplementation a game-changer, or could it mask other factors? And what about genetic differences in kids—do they influence outcomes more than we think? These questions challenge us to rethink prevention.
Conclusion
Low 25-(OH)-D, high NT-proBNP, and elevated inflammation markers may predict heart injury in MPP kids. But limitations like sampling bias and static snapshots call for dynamic, longitudinal studies. Future research should explore immune tweaks and biomarkers for deeper insights.
Data Access
Available from the lead author on request.
References
(Full list preserved, with links.)
Thanks
None.
Support
None.
Author Bios
¹ Pediatrics Dept., Zhangye People’s Hospital, Hexi University, Zhangye 734000, China
Yingjie Liu & Ping Li
Roles
YL and PL analyzed data, drafted text; conceived study, oversaw work.
Ethics
Approved by hospital committee; consent from guardians.
Publication Consent
N/A.
Conflicts
None.
Extra Info
Springer neutral on maps/affiliations.
Rights
Open under CC BY-NC-ND 4.0.
Citing This
Liu Y, Li P. Ties between 25-hydroxyvitamin D, NT-proBNP, inflammation, and heart damage in kids with MPP. BMC Pediatr 25, 914 (2025).
What do you think? Is vitamin D the overlooked hero in fighting MPP heart risks, or are inflammation markers more telling? Share your views in the comments—let's debate and learn together!
